A New Model for Heart Valve Disease Drug Discovery

A New Model for Heart Valve Disease Drug Discovery

Press Release (ePRNews.com) - WASHINGTON - Mar 15, 2019 - An article published in Experimental Biology and Medicine (Volume 244, Issue 3, February, 2019) (https://journals.sagepub.com/doi/pdf/10.1177/1535370219829006) describes a new model for heart valve physiology. The study, led by Dr. Carla Lacerda, from the Department of Chemical Engineering at Texas Tech University in Lubbock, TX, USA reports that 10 percent cyclic radial strain on isolated mitral valve anterior leaflets provides a true physiological environment that can be used for mechanistic studies and drug discovery.

Heart valves are responsible for maintaining a smooth flow of blood in one direction. Over 5 million Americans are estimated to live with a malfunctioning heart valve. Mechanical stresses (tensile and shear forces) are a major cause of valve degeneration. Valvular endothelial cells, one of the two types of cells comprising heart valves, can protect valves from degeneration. Understanding the molecular mechanisms used by these cells to respond to stress will provide new drug targets for treating valvular disease.

In the current study, Dr. Lacerda and colleagues used proteomic analysis to evaluate the effect of 10% cyclic radial strain on isolated heart valves. Stretch downregulated cytoskeletal proteins and proteins involved in energy metabolism, suggesting a quiescent state. Removal of the endothelium resulted in downregulation of extracellular matrix and cell-matrix adhesion proteins, suggesting a protective role of the endothelium in extracellular matrix homeostasis. Endothelium removal also upregulated protein synthesis activities. Collectively, these studies provide new insights regarding the molecular mechanisms that regulate heart valve response to mechanical stress. These studies also define a true physiological environment that can be used to study valve function as well as discover new drugs for preventing, slowing or reversing valve disease. Dr. Lacerda said that “Development of in vitro models to properly guide design of replacement tissues is key for the advancement of tissue engineering techniques. Only by developing physiology-mimicking constructs, in which cells behave as they do in vivo, will we be able to understand the molecular mechanisms employed by cells to defend themselves from environmental insults.”

Dr. Steven R. Goodman, Editor-in-Chief of Experimental Biology & Medicine, said, “Lacerda and colleagues provide a proteomic and interactomic analysis of proteins and protein networks affected by mitral valve mechanical stretch and/or endothelium removal. This will be a useful platform for future studies on heart valve pathophysiology.”

Experimental Biology and Medicine is a global journal dedicated to the publication of multidisciplinary and interdisciplinary research in the biomedical sciences. The journal was first established in 1903. Experimental Biology and Medicine is the journal of the Society of Experimental Biology and Medicine. To learn about the benefits of society membership visit www.sebm.org. If interested in publishing in the journal, please visit http://ebm.sagepub.com.

Source : Experimental Biology and Medicine
SHARE :  

You may also like this  

Login

Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Or form here

Already have an account ? Login

Reset Password

Already have an account ? Login

DISCLAIMER

If you have any concerns regarding this press release, please contact the Author / Media Contact / Business of this press release. ePRNews is not resposible for the accuracy of the news posted and do not endorse, support any product/ services/ business mentioned and hereby disclaims any content contained in this press release.